Medroxyprogesterone Acetate Suspension Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 150 mg/mL, 400 mg/mL
Reference Brands: Depo-Provera®(US & EU); Depo-Progestin®(EU)
Category:
Women's Health
Medroxyprogesterone Acetate Injection is a long-acting contraceptive and hormone therapy used for menstrual disorders and endometriosis. Available mainly as a 150 mg/mL intramuscular suspension (e.g., Depo-Provera®), it offers sustained release for effective women’s health management. Trusted across the US and EU, this injectable ensures compliance and convenience in clinical and family planning settings.
Medroxyprogesterone Acetate Suspension is available in Injection
and strengths such as 150 mg/mL, 400 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Medroxyprogesterone Acetate Suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Medroxyprogesterone Acetate Suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Medroxyprogesterone Acetate (MPA) Suspension Injection is a long-acting progestin widely used in women’s health for contraception, menstrual disorders, and endometriosis management. Available as an intramuscular injectable suspension, common strengths include 150 mg/mL for contraceptive use and 400 mg/mL for other therapeutic indications. Leading manufacturers in the US and EU produce GMP-certified formulations trusted by healthcare providers, clinics, and hospitals. The injection offers convenient, sustained-release progestin therapy, improving patient compliance and effective hormone regulation. It is an essential pharmaceutical product for women’s reproductive health management in clinical and outpatient settings.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing